Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
Immunotherapy improved efficacy and survival in selective patients with metastatic colorectal
cancer (mCRC), however, limited data revealed the landscape of immunotherapy efficacy. What's
more, potential markers have not been comprehensively evaluated to identify responding
patients to further improve efficacy.The investigators conducted a single-arm study to
investigate the efficacy of combination immunotherapy in patients with mCRC, and the combined
regimen is determined by the physician in charge.